SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

18.54 0.76

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.2

Max

18.96

Põhinäitajad
By Trading Economics
Sissetulek	-46M
Müük	-21M
Kasumimarginaal	221.361
Töötajad	103
EBITDA	-44M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+17.59% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	25. nov 2025

Turustatistika
By TradingEconomics
Turukapital	943M
Eelmine avamishind	17.78
Eelmine sulgemishind	18.54

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. nov 2025, 19:25 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18. nov 2025, 18:09 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18. nov 2025, 17:39 UTC

Omandamised, ülevõtmised, äriostud

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18. nov 2025, 16:25 UTC

Suurimad hinnamuutused turgudel

Diginex Rises on Deal With Digital Asset Platform Evident

18. nov 2025, 23:56 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18. nov 2025, 23:39 UTC

Market Talk

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18. nov 2025, 22:59 UTC

Market Talk

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18. nov 2025, 22:08 UTC

Market Talk

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18. nov 2025, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18. nov 2025, 22:03 UTC

Tulu

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18. nov 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. nov 2025, 21:15 UTC

Market Talk

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18. nov 2025, 20:46 UTC

Market Talk

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18. nov 2025, 20:13 UTC

Market Talk

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18. nov 2025, 19:48 UTC

Market Talk

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18. nov 2025, 19:19 UTC

Omandamised, ülevõtmised, äriostud

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18. nov 2025, 18:29 UTC

Tulu

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. nov 2025, 18:18 UTC

Market Talk

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18. nov 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

18. nov 2025, 17:19 UTC

Market Talk

Tulu

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18. nov 2025, 17:06 UTC

Tulu

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18. nov 2025, 16:06 UTC

Omandamised, ülevõtmised, äriostud

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18. nov 2025, 15:59 UTC

Tulu

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18. nov 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18. nov 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

17.59% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR 17.59%

Kõrge 25 EUR

Madal 21 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.